Werewolf Therapeutics

Werewolf develops therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
Series B
Initial Investment Year
2020
Werewolf Tx Hover Image